Karyopharm Therapeutics Inc
KPTI
$1.60-0.62%
End of day · as of Sep 14, 2026, 9:02 PM ET
Mkt cap
$205.55M
EV/Sales
0.99
P/E ratio
N/A
FY2025 Revenue
$146.07M
EPS (TTM)
$-19.06
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-134.21%
Beta
0.81
Div yield
N/A
Sector
Healthcare
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported KPTI revenue for 2025-12-31 was $146.1M. Net income was -$196.0M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. KPTI currently screens at market cap $205.6M.
Use this KPTI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KPTI income, balance, and cash tables.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company in the Healthcare sector.
Latest cached Karyopharm Therapeutics Inc (KPTI) revenue for Dec 31, 2025 was $146.1M. Net income was -$196.0M. Statements: https://lician.com/financials/kpti
Karyopharm Therapeutics Inc (KPTI) market capitalization is $205.6M on the latest cached snapshot.
Karyopharm Therapeutics Inc (KPTI) cached previous close $1.61; day range $1.55 – $1.62; volume 991,017. Session quote: https://lician.com/quote/kpti
Karyopharm Therapeutics Inc (KPTI) latest cached earnings event is "KPTI earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KPTI filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/kpti